D.A. Davidson & Co’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,302
Closed -$344K 2604
2016
Q4
$344K Buy
4,302
+1
+0% +$79 0.01% 787
2016
Q3
$342K Sell
4,301
-3,409
-44% -$275K 0.01% 760
2016
Q2
$599K Buy
7,710
+499
+7% +$35.6K 0.02% 500
2016
Q1
$394K Buy
7,211
+2,207
+44% +$120K 0.01% 599
2015
Q4
$308K Buy
5,004
+149
+3% +$9.4K 0.01% 699
2015
Q3
$305K Sell
4,855
-276
-5% -$19.7K 0.01% 677
2015
Q2
$373K Sell
5,131
-301
-6% -$21.7K 0.01% 657
2015
Q1
$354K Buy
5,432
+982
+22% +$65.3K 0.01% 677
2014
Q4
$288K Sell
4,450
-184
-4% -$11.8K 0.01% 750
2014
Q3
$277K Sell
4,634
-237
-5% -$15.5K 0.01% 765
2014
Q2
$335K Buy
4,871
+588
+14% +$38.1K 0.01% 709
2014
Q1
$279K Sell
4,283
-1,381
-24% -$89.9K 0.01% 765
2013
Q4
$350K Sell
5,664
-661
-10% -$38.3K 0.01% 688
2013
Q3
$338K Sell
6,325
-306
-5% -$15.8K 0.02% 580
2013
Q2
$301K Buy
+6,631
New +$287K 0.01% 572

Other funds holding STJ

D.A. Davidson & Co's STJ Position: Q1 2017 in Review

D.A. Davidson & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,302 shares — an estimated $344K sold.

D.A. Davidson & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $599K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • D.A. Davidson & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,302 St Jude Medical shares in Q1 2017, an estimated $344K.
  • D.A. Davidson & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • D.A. Davidson & Co's St Jude Medical position peaked at $599K in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.